Literature DB >> 1848374

Quantitative assessment of cerebral blood volume by single-photon emission computed tomography.

U Sabatini1, P Celsis, G Viallard, A Rascol, J P Marc-Vergnes.   

Abstract

We implemented a technique for measuring regional cerebral blood volume using single-photon emission computed tomography and in vivo technetium-99m-labeled red blood cells and then evaluated it in nine normal human volunteers (controls) and seven patients with bilateral occlusion or severe stenosis of the internal carotid artery. We also measured regional cerebral blood flow using single-photon emission computed tomography and intravenous xenon-133 in the same subjects. We studied regional cerebral blood flow, regional cerebral blood volume, and their ratio before and after the intravenous injection of 1 g acetazolamide. Mean +/- SD baseline regional cerebral blood volume was higher in the patients than in the controls (4.1 +/- 0.6 versus 3.2 +/- 0.3 ml/100 g, p less than 0.01), and mean +/- SD baseline regional cerebral blood flow was lower in the patients than in the controls (40.5 +/- 11 versus 55.6 +/- 11 ml/100 g/min, p less than 0.05). Acetazolamide induced similar mean +/- SD increases in regional cerebral blood volume in both the controls and the patients (0.3 +/- 0.1 and 0.3 +/- 0.2 ml/100 g), while the mean +/- SD regional cerebral blood flow reactivity was significantly less in the patients than in the controls (12.6 +/- 7.6 versus 24.5 +/- 9.6 ml/100 g/min, p less than 0.05). Our study shows that single-photon emission computed tomography can provide quantitative estimates of both regional cerebral blood volume and regional cerebral blood flow in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848374     DOI: 10.1161/01.str.22.3.324

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Simultaneous measurement of glucose transport and utilization in the human brain.

Authors:  Alexander A Shestov; Uzay E Emir; Anjali Kumar; Pierre-Gilles Henry; Elizabeth R Seaquist; Gülin Öz
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

2.  A study of acetazolamide-induced changes in cerebral blood flow using 99mTc HMPAO SPECT in patients with cerebrovascular disease.

Authors:  S Asenbaum; A Reinprecht; T Brücke; S Wenger; I Podreka; L Deecke
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

3.  Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.

Authors:  Trent J Volz; Sarah J Farnsworth; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurosci Methods       Date:  2008-10-17       Impact factor: 2.390

4.  Automated infarction core delineation using cerebral and perfused blood volume maps.

Authors:  Petr Maule; Jana Klečková; Vladimír Rohan; Radek Tupý
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-01-31       Impact factor: 2.924

5.  N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.

Authors:  Mary J Holmay; Melissa Terpstra; Lisa D Coles; Usha Mishra; Matthew Ahlskog; Gülin Öz; James C Cloyd; Paul J Tuite
Journal:  Clin Neuropharmacol       Date:  2013 Jul-Aug       Impact factor: 1.592

6.  Effects of acetazolamide on the micro- and macro-vascular cerebral hemodynamics: a diffuse optical and transcranial doppler ultrasound study.

Authors:  Peyman Zirak; Raquel Delgado-Mederos; Joan Martí-Fàbregas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2010-11-19       Impact factor: 3.732

7.  Regional cerebral blood flow and blood volume in patients with subcortical arteriosclerotic encephalopathy (SAE).

Authors:  Friedemann J Gückel; Gunnar Brix; Michael Hennerici; Robert Lucht; Christine Ueltzhöffer; Wolfgang Neff
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 7.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.